Day One Biopharmaceuticals, Inc.
NASDAQ:DAWN
13.79 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 230.784 | 85.262 | 284.309 | 43.728 | 27.332 |
| Short Term Investments
| 135.563 | 257.007 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 366.347 | 342.269 | 284.309 | 43.728 | 27.332 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 2.352 | 1.006 | 1.015 | 1.343 | 0.007 |
| Total Current Assets
| 375.274 | 347.874 | 289.368 | 45.071 | 27.339 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 0.56 | 0.719 | 0.284 | 0.483 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.214 | 0.469 | 0.169 | 0.107 | 0 |
| Total Non-Current Assets
| 0.774 | 1.188 | 0.453 | 0.59 | 0 |
| Total Assets
| 376.048 | 349.062 | 289.821 | 45.661 | 27.339 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 2.576 | 0.26 | 1.744 | 0.202 | 0.069 |
| Short Term Debt
| 0.408 | 0.405 | 0.204 | 0.198 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 25.483 | 0 | 6.605 | 1.569 | 0 |
| Other Current Liabilities
| 1.041 | 15.95 | 0.104 | 0.027 | 1.952 |
| Total Current Liabilities
| 29.508 | 16.615 | 8.657 | 1.996 | 2.021 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 0 | 0.408 | 0.016 | 0.204 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 91.964 | 0 |
| Total Non-Current Liabilities
| 0 | 0.408 | 0.016 | 92.168 | 30.504 |
| Total Liabilities
| 29.508 | 17.023 | 8.673 | 94.164 | 32.525 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 0 | 5.702 | 5.487 |
| Common Stock
| 0.009 | 0.007 | 0.006 | 2 | 2 |
| Retained Earnings
| -458.585 | -269.668 | -127.487 | -56.842 | -12.784 |
| Accumulated Other Comprehensive Income/Loss
| 0.009 | -0.071 | 0 | 0.001 | 0 |
| Other Total Stockholders Equity
| 805.107 | 0.064 | -0.006 | -5.066 | -5.376 |
| Total Shareholders Equity
| 346.54 | -269.668 | -127.487 | -54.205 | -10.673 |
| Total Equity
| 346.54 | -269.668 | 162.334 | -48.503 | -5.186 |
| Total Liabilities & Shareholders Equity
| 376.048 | -252.645 | -118.814 | 45.661 | 27.339 |